Boris Feld

1.1k total citations
26 papers, 724 citations indexed

About

Boris Feld is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Boris Feld has authored 26 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Boris Feld's work include Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (9 papers) and Herpesvirus Infections and Treatments (8 papers). Boris Feld is often cited by papers focused on Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (9 papers) and Herpesvirus Infections and Treatments (8 papers). Boris Feld collaborates with scholars based in United States, Canada and China. Boris Feld's co-authors include Jonathan D. Bloom, Thomas R. Jones, Juliette O’Connell, Kevin J. Curran, Mark Orlowski, Anita Y. M. Howe, John W. Ellingboe, Ariamala Gopalsamy, Martin DiGrandi and Bryan O’Hara and has published in prestigious journals such as Analytical Biochemistry, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Boris Feld

25 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Feld United States 16 330 197 194 177 165 26 724
Susan L. Binford United States 12 303 0.9× 408 2.1× 183 0.9× 420 2.4× 82 0.5× 15 1.1k
Frank Preugschat United States 16 179 0.5× 271 1.4× 139 0.7× 329 1.9× 175 1.1× 21 1000
Bruno Simoneau Canada 18 306 0.9× 348 1.8× 485 2.5× 338 1.9× 72 0.4× 35 1.2k
Tony Whitaker United States 17 410 1.2× 555 2.8× 192 1.0× 324 1.8× 436 2.6× 36 1.0k
Christopher Cianci United States 21 652 2.0× 238 1.2× 278 1.4× 433 2.4× 29 0.2× 38 1.1k
Jean Bernatchez United States 14 192 0.6× 201 1.0× 101 0.5× 287 1.6× 66 0.4× 46 713
Feng Cao United States 17 464 1.4× 182 0.9× 57 0.3× 172 1.0× 354 2.1× 31 898
B.K. Biswal India 16 147 0.4× 223 1.1× 38 0.2× 332 1.9× 159 1.0× 36 723
Kevin Steffy United States 15 407 1.2× 105 0.5× 79 0.4× 193 1.1× 153 0.9× 23 747
Giulio Nannetti Italy 14 371 1.1× 126 0.6× 165 0.9× 278 1.6× 58 0.4× 19 703

Countries citing papers authored by Boris Feld

Since Specialization
Citations

This map shows the geographic impact of Boris Feld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Feld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Feld more than expected).

Fields of papers citing papers by Boris Feld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Feld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Feld. The network helps show where Boris Feld may publish in the future.

Co-authorship network of co-authors of Boris Feld

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Feld. A scholar is included among the top collaborators of Boris Feld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Feld. Boris Feld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kwong, Cecil D., Jeremy L. Clark, Feng Geng, et al.. (2011). Novel substituted pyrimidines as HCV replication (replicase) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(2). 1160–1164. 4 indexed citations
2.
Tong, Xiao, Ashok Arasappan, Frank Bennett, et al.. (2010). Preclinical Characterization of the Antiviral Activity of SCH 900518 (Narlaprevir), a Novel Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease. Antimicrobial Agents and Chemotherapy. 54(6). 2365–2370. 30 indexed citations
3.
Tong, Xiao, Ashok Arasappan, Frank Bennett, et al.. (2009). 967 PRECLINICAL CHARACTERIZATION OF SCH 900518, A NOVEL MECHANISM-BASED INHIBITOR OF HCV NS3 PROTEASE. Journal of Hepatology. 50. S351–S351.
4.
Hou, Yan, Andrew Prongay, Boris Feld, et al.. (2008). Screening for Antiviral Inhibitors of the HIV Integrase–LEDGF/p75 Interaction Using the AlphaScreen™ Luminescent Proximity Assay. SLAS DISCOVERY. 13(5). 406–414. 40 indexed citations
5.
Miesel, Lynn, et al.. (2007). A high-throughput assay for the adenylation reaction of bacterial DNA ligase. Analytical Biochemistry. 366(1). 9–17. 12 indexed citations
6.
Gopalsamy, Ariamala, Mengxiao Shi, Kaapjoo Park, et al.. (2006). Design and synthesis of 2,3,4,9-tetrahydro-1H-carbazole and 1,2,3,4-tetrahydro-cyclopenta[b]indole derivatives as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 16(9). 2532–2534. 15 indexed citations
7.
8.
Gopalsamy, Ariamala, Rajiv Chopra, Mengxiao Shi, et al.. (2006). Discovery of Proline Sulfonamides as Potent and Selective Hepatitis C Virus NS5b Polymerase Inhibitors. Evidence for a New NS5b Polymerase Binding Site. Journal of Medicinal Chemistry. 49(11). 3052–3055. 46 indexed citations
9.
Gopalsamy, Ariamala, Kaapjoo Park, John W. Ellingboe, et al.. (2005). Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 16(2). 457–460. 33 indexed citations
10.
Visalli, Robert J., Martin J. Di Grandi, Jonathan D. Bloom, et al.. (2004). Thiourea Inhibitors of Herpesviruses Part 3: Inhibitors of VZV. Bioorganic & Medicinal Chemistry Letters. 14(16). 2 indexed citations
11.
Gopalsamy, Ariamala, John W. Ellingboe, Girija Krishnamurthy, et al.. (2004). Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 14(16). 4221–4224. 9 indexed citations
12.
Bloom, Jonathan D., Russell G. Dushin, Kevin J. Curran, et al.. (2004). Thiourea inhibitors of herpes viruses. Part 2: N-Benzyl-N′-arylthiourea inhibitors of CMV. Bioorganic & Medicinal Chemistry Letters. 14(13). 3401–3406. 54 indexed citations
13.
Grandi, Martin J. Di, Kevin J. Curran, Amar S. Prashad, et al.. (2004). Thiourea inhibitors of herpesviruses. Part 3: Inhibitors of varicella zoster virus. Bioorganic & Medicinal Chemistry Letters. 14(16). 4157–4160. 24 indexed citations
14.
Gopalsamy, Ariamala, Kaapjoo Park, John W. Ellingboe, et al.. (2004). Discovery of Pyrano[3,4-b]indoles as Potent and Selective HCV NS5B Polymerase Inhibitors. Journal of Medicinal Chemistry. 47(26). 6603–6608. 80 indexed citations
15.
Grandi, Martin J. Di, Kevin J. Curran, Amar S. Prashad, et al.. (2004). Thiourea Inhibitors of Herpesviruses. Part 3. Inhibitors of Varicella Zoster Virus.. ChemInform. 35(49). 1 indexed citations
16.
Jones, Thomas R., S V Johann, Vladimir I. Razinkov, et al.. (2004). Specific Inhibition of Human Cytomegalovirus Glycoprotein B-Mediated Fusion by a Novel Thiourea Small Molecule. Journal of Virology. 78(3). 1289–1300. 31 indexed citations
17.
Amin, Anthony A., Stéphane Olland, Mark Orlowski, et al.. (2003). Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase. Virology. 313(1). 158–169. 9 indexed citations
18.
Bloom, Jonathan D., Martin DiGrandi, Russell G. Dushin, et al.. (2003). Thiourea inhibitors of herpes viruses. part 1: bis-(aryl)thiourea inhibitors of CMV. Bioorganic & Medicinal Chemistry Letters. 13(17). 2929–2932. 41 indexed citations
19.
Alksne, Lefa, William Hu, Boris Feld, et al.. (2000). Identification and Analysis of Bacterial Protein Secretion Inhibitors Utilizing a SecA-LacZ Reporter Fusion System. Antimicrobial Agents and Chemotherapy. 44(6). 1418–1427. 42 indexed citations
20.
Ding, Weidong, Girija Krishnamurthy, Ann Aulabaugh, et al.. (1998). Novel and Specific Respiratory Syncytial Virus Inhibitors That Target Virus Fusion. Journal of Medicinal Chemistry. 41(15). 2671–2675. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan L. Binford Breakdown of academic impact, for papers by Frank Preugschat Breakdown of academic impact, for papers by Bruno Simoneau Breakdown of academic impact, for papers by Tony Whitaker Breakdown of academic impact, for papers by Christopher Cianci Breakdown of academic impact, for papers by Jean Bernatchez Breakdown of academic impact, for papers by Feng Cao Breakdown of academic impact, for papers by B.K. Biswal Breakdown of academic impact, for papers by Kevin Steffy Breakdown of academic impact, for papers by Giulio Nannetti
Rankless by CCL
2026